CHRISTOPHER SANG DON LEE MD.
Department:
STONY BROOK UROLOGY
Clinical Practice Began:
2002
Gender:
Male
Language(s) (other than English):
Japanese, Korean
Primary Medical Conditions Treated:
BLADDER CANCER
BPH
CANCER OF THE BLADDER (BLADDER CANCER)
CANCER OF THE PROSTATE (PROSTATE CANCER)
CLINICAL TRIALS
KIDNEY CANCER
LAPAROSCOPIC ONCOLOGY (PROSTATE)
LAPAROSCOPIC PYELOPLASTY
LAPAROSCOPIC SURGERY
NEOBLADDERS
PROSTATE CANCER
PSA
RADICAL CYSTECTOMY
RENAL CELL CARCINOMA
RESEARCH TRIALS (CLINICAL TRIALS)
TESTICULAR CANCER
TESTIS CANCER
TRANSITIONAL CELL CARCINOMA
TUMOR MARKERS
URETERO PELVIC JUNCTION OBSTRUCTION (UPJO)
UROLOGIC ONCOLOGY
UROLOGY
Education and Training
Residency:
Albert Einstein School of Medicine, Montefiore
Fellowship:
Urologic Oncology/ Tumor Immunology - National Cancer Institute
Academic
Year Appointed at Stony Brook:
2005
Honors, Awards and Grants:
American Foundation for Urologic Disease Scholar Award
National Research Award
Insurance Plans
AETNA
AFFINITY HEALTH PLAN
AMERICHOICE
APA PARTNERS
BEECH STREET
BLUE CROSS/BLUE SHIELD HMO
BLUE CROSS/BLUE SHIELD OTHER PLANS
BLUE CROSS/BLUE SHIELD PPO
BLUE CROSS/BLUE SHIELD SENIOR PLAN
CIGNA HMO
CIGNA PPO
EMPIRE PLAN
FIDELIS CARE NEW YORK
GHI CBP
GHI HMO
GREAT WEST HEALTHCARE
HEALTH NET
HEALTHFIRST
HEALTHNET FEDERAL SERVICES (TRICARE)
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
OXFORD FREEDOM PLAN
SUFFOLK HEALTH PLAN
UNITED HEALTHCARE
US FAMILY HEALTH PLAN
VYTRA (except SMART START)
Practice Sites
UROLOGY,
24 RESEARCH WAY,
SUITE 500,
EAST SETAUKET,
NY 11733-3453.
Ph.: 631-444-1910
Fax: 631-444-6256
UROLOGY,
3 EDMUND D PELLEGRINO RD,
STONY BROOK,
NY 11794-9450.
Ph.: 631-638-1000

My Notes
The current management and proper diagnosis of urologic cancers mandates a multi-disciplinary team approach. My practice facilitates the coordinated efforts of Urology, Radiation Oncology, Medical Oncology, and the translational research programs at Stony Brook to provide a personalized, cohesive multi-faceted treatment program for the benefit of our patients. Our urologic oncology program is dedicated to providing the most innovative and minimally invasive treatment options available today. We offer a complex array of laparoscopic and open surgeries as well as innovative clinical trials in prostate and bladder cancer vaccines.